Skip to main content
Erschienen in: International Urogynecology Journal 7/2012

01.07.2012 | Original Article

Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction

verfasst von: Olga Ramm, Jonathan L. Gleason, Saya Segal, Danielle D. Antosh, Kimberly S. Kenton

Erschienen in: International Urogynecology Journal | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Uterine morcellation during laparoscopy for pelvic floor repair has prompted adoption of uterine screening tests by some surgeons. We report a case series of uterine malignancy incidentally diagnosed at the time of pelvic floor surgery.

Methods

We reviewed records from patients undergoing hysterectomy for pelvic organ prolapse (POP) and/or urinary incontinence (UI) from January 2004 to December 2009 and abstracted preoperative screening trends and final pathologic diagnoses.

Results

Of the 708 women in the study, 125 (18%) had preoperative endometrial biopsy (EB), 43 (6%) had pelvic ultrasound (US), and 21 (3%) had EB and US. Surgical route included vaginal (58%), abdominal (23%), and laparoscopic (18%). Most (97.1%) final pathologic diagnoses were benign. Five cancers (0.6%) were detected; four of these women had normal preoperative screening, including EB (2), US (1), or both tests (1).

Conclusions

Screening with EB + US was found to be ineffective in our cohort of patients due to the low prevalence of undetected uterine cancer in asymptomatic women planning POP/UI surgery.
Literatur
1.
Zurück zum Zitat Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG (2007) Hysterectomy rates in the United States, 2003. Obstet Gynecol 110(5):1091–1095PubMedCrossRef Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG (2007) Hysterectomy rates in the United States, 2003. Obstet Gynecol 110(5):1091–1095PubMedCrossRef
2.
Zurück zum Zitat Subak LL, Waetjen E, van den Eeden S, Thom DH, Vittinghoff E, Brown JS (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98(4):646–651PubMedCrossRef Subak LL, Waetjen E, van den Eeden S, Thom DH, Vittinghoff E, Brown JS (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98(4):646–651PubMedCrossRef
3.
Zurück zum Zitat Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, Zyczynski H, Pelvic Floor Disorders Network (2004) Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol 104(4):805–823PubMedCrossRef Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, Zyczynski H, Pelvic Floor Disorders Network (2004) Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol 104(4):805–823PubMedCrossRef
4.
Zurück zum Zitat Tan-Kim J, Menefee SA, Luber KM, Nager CW, Lukacz ES (2011) Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. Int Urogynecol J 22:(2):205–212PubMedCrossRef Tan-Kim J, Menefee SA, Luber KM, Nager CW, Lukacz ES (2011) Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. Int Urogynecol J 22:(2):205–212PubMedCrossRef
5.
Zurück zum Zitat Bensinger G, Lind L, Lesser M, Guess M, Winkler HA (2005) Abdominal sacral suspensions: analysis of complications using permanent mesh. Am J Obstet Gynecol 193(6):2094–2098PubMedCrossRef Bensinger G, Lind L, Lesser M, Guess M, Winkler HA (2005) Abdominal sacral suspensions: analysis of complications using permanent mesh. Am J Obstet Gynecol 193(6):2094–2098PubMedCrossRef
6.
Zurück zum Zitat Kumar S, Sharma JB, Verma D, Gupta P, Roy KK, Malhotra N (2008) Disseminated peritoneal leiomyomatosis: an unusual complication of laparoscopic myomectomy. Arch Gynecol Obstet 278(1):93–95PubMedCrossRef Kumar S, Sharma JB, Verma D, Gupta P, Roy KK, Malhotra N (2008) Disseminated peritoneal leiomyomatosis: an unusual complication of laparoscopic myomectomy. Arch Gynecol Obstet 278(1):93–95PubMedCrossRef
7.
Zurück zum Zitat Einstein MH, Barakat RR, Chi DS, Sonoda Y, Alektiar KM, Hensley ML, Abu-Rustum NR (2008) Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer 18:1065–1070PubMedCrossRef Einstein MH, Barakat RR, Chi DS, Sonoda Y, Alektiar KM, Hensley ML, Abu-Rustum NR (2008) Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer 18:1065–1070PubMedCrossRef
8.
Zurück zum Zitat Frick AC, Walters MD, Larkin KS, Barber MD (2010) Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol 202(5):e1–e4, 507PubMedCrossRef Frick AC, Walters MD, Larkin KS, Barber MD (2010) Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol 202(5):e1–e4, 507PubMedCrossRef
9.
Zurück zum Zitat ACOG Committee Opinion 388: supracervical hysterectomy. November 2007, reaffirmed 2010 ACOG Committee Opinion 388: supracervical hysterectomy. November 2007, reaffirmed 2010
10.
Zurück zum Zitat Stovall TG, Photopulos GJ, Poston WM, Ling FW, Sandles LG (1991) Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol 77:954–956PubMed Stovall TG, Photopulos GJ, Poston WM, Ling FW, Sandles LG (1991) Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol 77:954–956PubMed
11.
Zurück zum Zitat Zorlu CG, Cobanoglu O, Işik AZ, Kutluay L, Kuşçu E (1994) Accuracy of pipelle endometrial sampling in endometrial carcinoma. Gynecol Obstet Invest 38:272–275PubMedCrossRef Zorlu CG, Cobanoglu O, Işik AZ, Kutluay L, Kuşçu E (1994) Accuracy of pipelle endometrial sampling in endometrial carcinoma. Gynecol Obstet Invest 38:272–275PubMedCrossRef
12.
Zurück zum Zitat Rodriguez GC, Yaqub N, King ME (1993) A comparison of the Pipelle device and the Vabra aspirator as measured by endometrial denudation in hysterectomy specimens: the Pipelle device samples significantly less of the endometrial surface than the Vabra aspirator. Am J Obstet Gynecol 168:55–59PubMed Rodriguez GC, Yaqub N, King ME (1993) A comparison of the Pipelle device and the Vabra aspirator as measured by endometrial denudation in hysterectomy specimens: the Pipelle device samples significantly less of the endometrial surface than the Vabra aspirator. Am J Obstet Gynecol 168:55–59PubMed
13.
Zurück zum Zitat Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA (1995) Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer. J Reprod Med 40:553–555PubMed Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA (1995) Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer. J Reprod Med 40:553–555PubMed
Metadaten
Titel
Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction
verfasst von
Olga Ramm
Jonathan L. Gleason
Saya Segal
Danielle D. Antosh
Kimberly S. Kenton
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 7/2012
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-012-1694-2

Weitere Artikel der Ausgabe 7/2012

International Urogynecology Journal 7/2012 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.